| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 19.87M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RX.V returned +31.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +22.7% |
| 1 year | +31.1% |
| 5 years | +121.5% |
| 10 years | +107.6% |
| All-time high | $15.79 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RX.V would be worth today ›Yes. BioSyent Inc. paid 4 dividends over the past 12 months. The most recent was $0.06 per share on May 29, 2026. The dividend yield is 1.40%.
BioSyent Inc. is part of the Healthcare sector.
BioSyent Inc. has a market cap of 175.35M CAD, based on the latest quote.
BioSyent Inc. is expected to report earnings around Nov 19, 2026. That date is an estimate and has not been confirmed by the company.
